ARTPred Competitors and Similar CompaniesClear all
ARTPred's competitors and similar companies include Kymab and Alcresta.
 ARTPred ARTPred is a research driven biotech company in the field of IVF. ARTPred is dedicated to develop a predictive test (PREDICTIFE) for embryo implantation, ased on urinary and vaginal microbiome profiling. |  Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. |  Alcresta Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2009 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations 's-Hertogenbosch, NL HQ | Locations Cambridge, GB HQ | Locations Newton, US HQ |
Employees | Employees 5 | Employees 407% decrease | Employees 82 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 100m (over 9 years ago) | Latest funding round $ 60m (over 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 220.4m | Total funding raised $ 139.4m |
For sources of this data, please see the company profile
View Company Profiles
Kymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View companyAlcresta
HQ
Newton, US
Employees
82
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
View company